{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:12:21Z","timestamp":1770819141426,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10741-019-09900-3","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T10:09:45Z","timestamp":1576577385000},"page":"81-89","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association between evidence-based medication at discharge and outcomes in patients with heart failure: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"26","author":[{"given":"Jia-Li","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiwen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,17]]},"reference":[{"issue":"27","key":"9900_CR1","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 37(27):2129\u20132200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"issue":"1","key":"9900_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ahj.2004.03.004","volume":"148","author":"GC Fonarow","year":"2004","unstructured":"Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O'Connor CM, Yancy CW, Young J (2004) Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design. Am Heart J 148(1):43\u201351. https:\/\/doi.org\/10.1016\/j.ahj.2004.03.004","journal-title":"Am Heart J"},{"issue":"6","key":"9900_CR3","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"W Yancy Clyde","year":"2017","unstructured":"Yancy Clyde W, Jessup M, Bozkurt B, Butler J, Casey Donald E, Colvin Monica M, Drazner Mark H, Filippatos Gerasimos S, Fonarow Gregg C, Givertz Michael M, Hollenberg Steven M, Lindenfeld J, Masoudi Frederick A, McBride Patrick E, Peterson Pamela N, Stevenson Lynne W, Westlake C (2017) 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America. Circulation 136(6):e137\u2013e161. https:\/\/doi.org\/10.1161\/CIR.0000000000000509","journal-title":"Circulation"},{"issue":"2","key":"9900_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10741-014-9453-8","volume":"20","author":"C Bavishi","year":"2015","unstructured":"Bavishi C, Chatterjee S, Ather S, Patel D, Messerli FH (2015) Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis. Heart Fail Rev 20(2):193\u2013201. https:\/\/doi.org\/10.1007\/s10741-014-9453-8","journal-title":"Heart Fail Rev"},{"issue":"9215","key":"9900_CR5","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","volume":"355","author":"MD Flather","year":"2000","unstructured":"Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, Torp-Pedersen C, Ball S, Pogue J, Moye L, Braunwald E (2000) Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-inhibitor myocardial infarction collaborative group. Lancet 355(9215):1575\u20131581","journal-title":"Lancet"},{"issue":"8","key":"9900_CR6","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.jacc.2005.11.073","volume":"47","author":"MH Al-Mallah","year":"2006","unstructured":"Al-Mallah MH, Tleyjeh IM, Abdel-Latif AA, Weaver WD (2006) Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials. J Am Coll Cardiol 47(8):1576\u20131583. https:\/\/doi.org\/10.1016\/j.jacc.2005.11.073","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"9900_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S1388-9842(01)00144-1","volume":"3","author":"MC Shibata","year":"2001","unstructured":"Shibata MC, Flather MD, Wang D (2001) Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. Eur J Heart Fail 3(3):351\u2013357","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"9900_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100. https:\/\/doi.org\/10.1371\/journal.pmed.1000100","journal-title":"PLoS Med"},{"issue":"6","key":"9900_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.7326\/0003-4819-144-6-200603210-00010","volume":"144","author":"JA Hayden","year":"2006","unstructured":"Hayden JA, Cote P, Bombardier C (2006) Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 144(6):427\u2013437","journal-title":"Ann Intern Med"},{"issue":"2","key":"9900_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","volume":"28","author":"R DerSimonian","year":"2007","unstructured":"DerSimonian R, Kacker R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28(2):105\u2013114","journal-title":"Contemp Clin Trials"},{"issue":"11","key":"9900_CR11","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","volume":"53","author":"JAC Sterne","year":"2000","unstructured":"Sterne JAC, Gavaghan D, Egger M (2000) Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 53(11):1119\u20131129. https:\/\/doi.org\/10.1016\/S0895-4356(00)00242-0","journal-title":"J Clin Epidemiol"},{"issue":"23","key":"9900_CR12","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","volume":"359","author":"BM Massie","year":"2008","unstructured":"Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359(23):2456\u20132467. https:\/\/doi.org\/10.1056\/NEJMoa0805450","journal-title":"N Engl J Med"},{"issue":"9386","key":"9900_CR13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/s0140-6736(03)14285-7","volume":"362","author":"S Yusuf","year":"2003","unstructured":"Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial. Lancet 362(9386):777\u2013781. https:\/\/doi.org\/10.1016\/s0140-6736(03)14285-7","journal-title":"Lancet"},{"issue":"19","key":"9900_CR14","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","volume":"27","author":"JG Cleland","year":"2006","unstructured":"Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J (2006) The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 27(19):2338\u20132345. https:\/\/doi.org\/10.1093\/eurheartj\/ehl250","journal-title":"Eur Heart J"},{"issue":"2","key":"9900_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/CIRCHEARTFAILURE.112.000115","volume":"6","author":"H Lund Lars","year":"2013","unstructured":"Lund Lars H, Svennblad B, Melhus H, Hallberg P, Dahlstr\u00f6m U, Edner M (2013) Association of spironolactone use with all-cause mortality in heart failure. Circ Heart Fail 6(2):174\u2013183. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.000115","journal-title":"Circ Heart Fail"},{"issue":"2","key":"9900_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.amjcard.2007.08.050","volume":"101","author":"R Shah","year":"2008","unstructured":"Shah R, Wang Y, Foody JM (2008) Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function. Am J Cardiol 101(2):217\u2013222. https:\/\/doi.org\/10.1016\/j.amjcard.2007.08.050","journal-title":"Am J Cardiol"},{"issue":"2","key":"9900_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jacc.2008.09.031","volume":"53","author":"AF Hernandez","year":"2009","unstructured":"Hernandez AF, Hammill BG, O'Connor CM, Schulman KA, Curtis LH, Fonarow GC (2009) Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (organized program to initiate lifesaving treatment in hospitalized patients with heart failure) registry. J Am Coll Cardiol 53(2):184\u2013192. https:\/\/doi.org\/10.1016\/j.jacc.2008.09.031","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"9900_CR18","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.amjmed.2018.07.008","volume":"131","author":"PH Lam","year":"2018","unstructured":"Lam PH, Gupta N, Dooley DJ, Singh S, Deedwania P, Zile MR, Bhatt DL, Morgan CJ, Pitt B, Fonarow GC, Ahmed A (2018) Role of high-dose Beta-blockers in patients with heart failure with preserved ejection fraction and elevated heart rate. Am J Med 131(12):1473\u20131481. https:\/\/doi.org\/10.1016\/j.amjmed.2018.07.008","journal-title":"Am J Med"},{"issue":"7","key":"9900_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.amjmed.2014.11.036","volume":"128","author":"V Bhatia","year":"2015","unstructured":"Bhatia V, Bajaj NS, Sanam K, Hashim T, Morgan CJ, Prabhu SD, Fonarow GC, Deedwania P, Butler J, Carson P, Love TE, Kheirbek R, Aronow WS, Anker SD, Waagstein F, Fletcher R, Allman RM, Ahmed A (2015) Beta-blocker use and 30-day all-cause readmission in Medicare beneficiaries with systolic heart failure. Am J Med 128(7):715\u2013721. https:\/\/doi.org\/10.1016\/j.amjmed.2014.11.036","journal-title":"Am J Med"},{"issue":"6","key":"9900_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12464","volume":"36","author":"X Qin","year":"2018","unstructured":"Qin X, Hung J, Knuiman M, Teng TK, Briffa T, Sanfilippo FM (2018) Evidence-based pharmacotherapies used in the postdischarge phase are associated with improved one-year survival in senior patients hospitalized with heart failure. Cardiovasc Ther 36(6):e12464. https:\/\/doi.org\/10.1111\/1755-5922.12464","journal-title":"Cardiovasc Ther"},{"issue":"2","key":"9900_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/ejhf.901","volume":"20","author":"E Platz","year":"2018","unstructured":"Platz E, Jhund PS, Claggett BL, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Solomon SD, McMurray JJ (2018) Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality. Eur J Heart Fail 20(2):295\u2013303. https:\/\/doi.org\/10.1002\/ejhf.901","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"9900_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/ejhf.682","volume":"19","author":"M Arrigo","year":"2017","unstructured":"Arrigo M, Gayat E, Parenica J, Ishihara S, Zhang J, Choi DJ, Park JJ, Alhabib KF, Sato N, Miro O, Maggioni AP, Zhang Y, Spinar J, Cohen-Solal A, Iwashyna TJ, Mebazaa A (2017) Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry. Eur J Heart Fail 19(2):201\u2013208. https:\/\/doi.org\/10.1002\/ejhf.682","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"9900_CR23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/archinte.168.8.847","volume":"168","author":"GC Fonarow","year":"2008","unstructured":"Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy CW, Young JB (2008) Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med 168(8):847\u2013854. https:\/\/doi.org\/10.1001\/archinte.168.8.847","journal-title":"Arch Intern Med"},{"issue":"8","key":"9900_CR24","doi-asserted-by":"publisher","first-page":"e3122","DOI":"10.7759\/cureus.3122","volume":"10","author":"MR Vindhyal","year":"2018","unstructured":"Vindhyal MR, Khayyat S, Shaaban A, Duran BA, Kallail KJ (2018) Decreased renal function is associated with heart failure readmissions. Cureus 10(8):e3122\u2013e3122. https:\/\/doi.org\/10.7759\/cureus.3122","journal-title":"Cureus"},{"issue":"2","key":"9900_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ehf2.12021","volume":"1","author":"MR Cowie","year":"2014","unstructured":"Cowie MR, Anker SD, Cleland JGF, Felker GM, Filippatos G, Jaarsma T, Jourdain P, Knight E, Massie B, Ponikowski P, L\u00f3pez-Send\u00f3n J (2014) Improving care for patients with acute heart failure: before, during and after hospitalization. ESC Heart Failure 1(2):110\u2013145. https:\/\/doi.org\/10.1002\/ehf2.12021","journal-title":"ESC Heart Failure"},{"issue":"9","key":"9900_CR26","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.cardfail.2007.06.727","volume":"13","author":"GC Fonarow","year":"2007","unstructured":"Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB (2007) Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF. J Card Fail 13(9):722\u2013731. https:\/\/doi.org\/10.1016\/j.cardfail.2007.06.727","journal-title":"J Card Fail"},{"issue":"4","key":"9900_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.amjmed.2011.10.013","volume":"125","author":"A Ahmed","year":"2012","unstructured":"Ahmed A, Fonarow GC, Zhang Y, Sanders PW, Allman RM, Arnett DK, Feller MA, Love TE, Aban IB, Levesque R, Ekundayo OJ, Dell'Italia LJ, Bakris GL, Rich MW (2012) Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease. Am J Med 125(4):399\u2013410. https:\/\/doi.org\/10.1016\/j.amjmed.2011.10.013","journal-title":"Am J Med"},{"issue":"1\u20132","key":"9900_CR28","first-page":"35","volume":"53","author":"BM Al-Meslmani","year":"2007","unstructured":"Al-Meslmani BM, Fahoum SK, Shamia MG (2007) NT-proBNP in monitoring treatment of patients with congestive heart failure. Clin Lab 53(1\u20132):35\u201339","journal-title":"Clin Lab"},{"issue":"10","key":"9900_CR29","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341(10):709\u2013717. https:\/\/doi.org\/10.1056\/NEJM199909023411001","journal-title":"N Engl J Med"},{"issue":"1","key":"9900_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2010","unstructured":"Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B (2010) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364(1):11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1009492","journal-title":"N Engl J Med"},{"issue":"15","key":"9900_CR31","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","volume":"370","author":"B Pitt","year":"2014","unstructured":"Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O'Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM (2014) Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 370(15):1383\u20131392. https:\/\/doi.org\/10.1056\/NEJMoa1313731","journal-title":"N Engl J Med"},{"issue":"4","key":"9900_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/aje\/kwh221","volume":"160","author":"S Greenland","year":"2004","unstructured":"Greenland S (2004) Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. Am J Epidemiol 160(4):301\u2013305. https:\/\/doi.org\/10.1093\/aje\/kwh221","journal-title":"Am J Epidemiol"},{"issue":"5","key":"9900_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/eurheartj\/ehv464","volume":"37","author":"SD Solomon","year":"2016","unstructured":"Solomon SD, Claggett B, Lewis EF, Desai A, Anand I, Sweitzer NK, O'Meara E, Shah SJ, McKinlay S, Fleg JL, Sopko G, Pitt B, Pfeffer MA (2016) Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur Heart J 37(5):455\u2013462. https:\/\/doi.org\/10.1093\/eurheartj\/ehv464","journal-title":"Eur Heart J"},{"issue":"14","key":"9900_CR34","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1161\/circulationaha.117.027324","volume":"135","author":"CS Lam","year":"2017","unstructured":"Lam CS, Solomon SD (2017) Fussing over the middle child: heart failure with mid-range ejection fraction. Circulation 135(14):1279\u20131280. https:\/\/doi.org\/10.1161\/circulationaha.117.027324","journal-title":"Circulation"},{"issue":"12","key":"9900_CR35","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/ejhf.945","volume":"19","author":"AS Koh","year":"2017","unstructured":"Koh AS, Tay WT, Teng THK, Vedin O, Benson L, Dahlstrom U, Savarese G, Lam CSP, Lund LH (2017) A comprehensive population-based characterization of heart failure with mid-range ejection fraction. Eur J Heart Fail 19(12):1624\u20131634. https:\/\/doi.org\/10.1002\/ejhf.945","journal-title":"Eur J Heart Fail"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09900-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-019-09900-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09900-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T15:06:21Z","timestamp":1609254381000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-019-09900-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,17]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["9900"],"URL":"https:\/\/doi.org\/10.1007\/s10741-019-09900-3","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,17]]},"assertion":[{"value":"17 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}